{"id":295834,"date":"2026-10-27T08:13:12","date_gmt":"2026-10-27T07:13:12","guid":{"rendered":"https:\/\/geneveinfos.ch\/2026\/10\/27\/resultats-trimestriels-un-echec-clinique-ampute-de-70-le-benefice-net-de-novartis\/"},"modified":"2026-10-31T11:53:03","modified_gmt":"2026-10-31T10:53:03","slug":"resultats-trimestriels-un-echec-clinique-ampute-de-70-le-benefice-net-de-novartis","status":"publish","type":"post","link":"https:\/\/geneveinfos.ch\/en\/2026\/10\/27\/resultats-trimestriels-un-echec-clinique-ampute-de-70-le-benefice-net-de-novartis\/","title":{"rendered":"Quarterly results: a clinical failure cuts Novartis\u2019 net profit by 70%"},"content":{"rendered":"<p><strong>The key point:<\/strong> Novartis booked an impairment of almost 2 billion dollars in the third quarter after a failed clinical trial, cutting its net profit by 70%.<\/p>\n<h3>The clinical failure<\/h3>\n<ul>\n<li><strong>Treatment:<\/strong> del-desiran, for myotonic dystrophy type 1, a rare genetic disease.<\/li>\n<li><strong>Consequence:<\/strong> net profit reduced to 1.20 billion dollars.<\/li>\n<\/ul>\n<h3>Underlying business<\/h3>\n<ul>\n<li><strong>Revenue:<\/strong> up 4.4%, above analysts\u2019 consensus.<\/li>\n<li><strong>Profitability:<\/strong> the adjusted operating margin rises by 2.3 points.<\/li>\n<\/ul>\n<h3>Key figures<\/h3>\n<ul>\n<li><strong>14.52 billion $:<\/strong> quarterly revenue.<\/li>\n<li><strong>41,6 % :<\/strong> adjusted operating margin.<\/li>\n<li><strong>6.04 billion $:<\/strong> adjusted operating income, up 10.5%.<\/li>\n<\/ul>\n<h3>In short<\/h3>\n<p>Excluding the impairment, Novartis beat expectations. A single failed trial weighs heavily on reported profit.<\/p>\n<p class=\"gi-source\"><a href=\"https:\/\/www.tdg.ch\/novartis-un-echec-clinique-ampute-70-du-benefice-trimestriel-664424126874\" target=\"_blank\" rel=\"noopener nofollow\">Read the full article on Tribune de Gen\u00e8ve \u2192<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Novartis booked an impairment of almost 2 billion dollars in the third quarter after a failed clinical trial, cutting its net profit by 70%.<\/p>","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[102],"tags":[127],"class_list":["post-295834","post","type-post","status-publish","format-standard","hentry","category-pharma-biotech","tag-fiche-bilingue"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.4 - aioseo.com -->\n\t<meta name=\"description\" content=\"Novartis a pass\u00e9 une d\u00e9pr\u00e9ciation de pr\u00e8s de 2 milliards de dollars au troisi\u00e8me trimestre apr\u00e8s l\u2019\u00e9chec d\u2019une \u00e9tude clinique, ce qui fait chuter son b\u00e9n\u00e9fice net de 70 %.\" \/>\n\t<meta name=\"robots\" content=\"noindex, max-image-preview:large, follow\" \/>\n\t<meta name=\"author\" content=\"R\u00e9daction Gen\u00e8ve Infos\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/geneveinfos.ch\/en\/2026\/10\/27\/resultats-trimestriels-un-echec-clinique-ampute-de-70-le-benefice-net-de-novartis\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.4\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_GB\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Gen\u00e8ve Infos - Le site d&#039;informations de la r\u00e9gion genevoise\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"R\u00e9sultats trimestriels : un \u00e9chec clinique ampute de 70 % le b\u00e9n\u00e9fice net de Novartis - Gen\u00e8ve Infos\" \/>\n\t\t<meta property=\"og:description\" content=\"Novartis a pass\u00e9 une d\u00e9pr\u00e9ciation de pr\u00e8s de 2 milliards de dollars au troisi\u00e8me trimestre apr\u00e8s l\u2019\u00e9chec d\u2019une \u00e9tude clinique, ce qui fait chuter son b\u00e9n\u00e9fice net de 70 %.\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/geneveinfos.ch\/en\/2026\/10\/27\/resultats-trimestriels-un-echec-clinique-ampute-de-70-le-benefice-net-de-novartis\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/geneveinfos.ch\/wp-content\/uploads\/2026\/10\/geneveinfos-partage-1200x630-1.jpg\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/geneveinfos.ch\/wp-content\/uploads\/2026\/10\/geneveinfos-partage-1200x630-1.jpg\" \/>\n\t\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-10-27T07:13:12+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-10-31T10:53:03+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61576016541234\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"R\u00e9sultats trimestriels : un \u00e9chec clinique ampute de 70 % le b\u00e9n\u00e9fice net de Novartis - Gen\u00e8ve Infos\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Novartis a pass\u00e9 une d\u00e9pr\u00e9ciation de pr\u00e8s de 2 milliards de dollars au troisi\u00e8me trimestre apr\u00e8s l\u2019\u00e9chec d\u2019une \u00e9tude clinique, ce qui fait chuter son b\u00e9n\u00e9fice net de 70 %.\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/geneveinfos.ch\/wp-content\/uploads\/2026\/10\/geneveinfos-partage-1200x630-1.jpg\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/10\\\/27\\\/resultats-trimestriels-un-echec-clinique-ampute-de-70-le-benefice-net-de-novartis\\\/#blogposting\",\"name\":\"R\\u00e9sultats trimestriels : un \\u00e9chec clinique ampute de 70 % le b\\u00e9n\\u00e9fice net de Novartis - Gen\\u00e8ve Infos\",\"headline\":\"R\\u00e9sultats trimestriels : un \\u00e9chec clinique ampute de 70 % le b\\u00e9n\\u00e9fice net de Novartis\",\"author\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/author\\\/wpra-source-author-site-1\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/geneveinfos.ch\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/geneve_infos_logo.png\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/#articleImage\"},\"datePublished\":\"2026-10-27T08:13:12+01:00\",\"dateModified\":\"2026-10-31T11:53:03+01:00\",\"inLanguage\":\"en-GB\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/10\\\/27\\\/resultats-trimestriels-un-echec-clinique-ampute-de-70-le-benefice-net-de-novartis\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/10\\\/27\\\/resultats-trimestriels-un-echec-clinique-ampute-de-70-le-benefice-net-de-novartis\\\/#webpage\"},\"articleSection\":\"Pharma &amp; biotech, Fiche bilingue\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/10\\\/27\\\/resultats-trimestriels-un-echec-clinique-ampute-de-70-le-benefice-net-de-novartis\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/category\\\/pharma-biotech\\\/#listItem\",\"name\":\"Pharma &amp; biotech\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/category\\\/pharma-biotech\\\/#listItem\",\"position\":2,\"name\":\"Pharma &amp; biotech\",\"item\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/category\\\/pharma-biotech\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/10\\\/27\\\/resultats-trimestriels-un-echec-clinique-ampute-de-70-le-benefice-net-de-novartis\\\/#listItem\",\"name\":\"R\\u00e9sultats trimestriels : un \\u00e9chec clinique ampute de 70 % le b\\u00e9n\\u00e9fice net de Novartis\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/10\\\/27\\\/resultats-trimestriels-un-echec-clinique-ampute-de-70-le-benefice-net-de-novartis\\\/#listItem\",\"position\":3,\"name\":\"R\\u00e9sultats trimestriels : un \\u00e9chec clinique ampute de 70 % le b\\u00e9n\\u00e9fice net de Novartis\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/category\\\/pharma-biotech\\\/#listItem\",\"name\":\"Pharma &amp; biotech\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/#organization\",\"name\":\"Gen\\u00e8ve Infos\",\"description\":\"Revue de presse et analyses sur l'\\u00e9conomie et l'urbanisme de Gen\\u00e8ve.\",\"url\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/geneveinfos.ch\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/geneve_infos_logo.png\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/10\\\/27\\\/resultats-trimestriels-un-echec-clinique-ampute-de-70-le-benefice-net-de-novartis\\\/#organizationLogo\"},\"image\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/10\\\/27\\\/resultats-trimestriels-un-echec-clinique-ampute-de-70-le-benefice-net-de-novartis\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61576016541234\",\"https:\\\/\\\/www.instagram.com\\\/geneveinfos.ch?igsh=MXhkaTV2bXBkZm00NQ==\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/geneveinfos-ch\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/author\\\/wpra-source-author-site-1\\\/#author\",\"url\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/author\\\/wpra-source-author-site-1\\\/\",\"name\":\"R\\u00e9daction Gen\\u00e8ve Infos\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/10\\\/27\\\/resultats-trimestriels-un-echec-clinique-ampute-de-70-le-benefice-net-de-novartis\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4a611ac9406717aef02499144d0e12a8f5e1327b66a2e6023de2c094c4937e1d?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"R\\u00e9daction Gen\\u00e8ve Infos\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/10\\\/27\\\/resultats-trimestriels-un-echec-clinique-ampute-de-70-le-benefice-net-de-novartis\\\/#webpage\",\"url\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/10\\\/27\\\/resultats-trimestriels-un-echec-clinique-ampute-de-70-le-benefice-net-de-novartis\\\/\",\"name\":\"R\\u00e9sultats trimestriels : un \\u00e9chec clinique ampute de 70 % le b\\u00e9n\\u00e9fice net de Novartis - Gen\\u00e8ve Infos\",\"description\":\"Novartis a pass\\u00e9 une d\\u00e9pr\\u00e9ciation de pr\\u00e8s de 2 milliards de dollars au troisi\\u00e8me trimestre apr\\u00e8s l\\u2019\\u00e9chec d\\u2019une \\u00e9tude clinique, ce qui fait chuter son b\\u00e9n\\u00e9fice net de 70 %.\",\"inLanguage\":\"en-GB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/10\\\/27\\\/resultats-trimestriels-un-echec-clinique-ampute-de-70-le-benefice-net-de-novartis\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/author\\\/wpra-source-author-site-1\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/author\\\/wpra-source-author-site-1\\\/#author\"},\"datePublished\":\"2026-10-27T08:13:12+01:00\",\"dateModified\":\"2026-10-31T11:53:03+01:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/\",\"name\":\"Gen\\u00e8ve Infos\",\"description\":\"Le site d'informations de la r\\u00e9gion genevoise\",\"inLanguage\":\"en-GB\",\"publisher\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Quarterly results: a clinical failure cuts Novartis\u2019 net profit by 70% - Gen\u00e8ve Infos","description":"Novartis booked an impairment of almost 2 billion dollars in the third quarter after a failed clinical trial, cutting its net profit by 70%.","canonical_url":"https:\/\/geneveinfos.ch\/en\/2026\/10\/27\/resultats-trimestriels-un-echec-clinique-ampute-de-70-le-benefice-net-de-novartis\/","robots":"noindex, max-image-preview:large, follow","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/geneveinfos.ch\/en\/2026\/10\/27\/resultats-trimestriels-un-echec-clinique-ampute-de-70-le-benefice-net-de-novartis\/#blogposting","name":"R\u00e9sultats trimestriels : un \u00e9chec clinique ampute de 70 % le b\u00e9n\u00e9fice net de Novartis - Gen\u00e8ve Infos","headline":"R\u00e9sultats trimestriels : un \u00e9chec clinique ampute de 70 % le b\u00e9n\u00e9fice net de Novartis","author":{"@id":"https:\/\/geneveinfos.ch\/en\/author\/wpra-source-author-site-1\/#author"},"publisher":{"@id":"https:\/\/geneveinfos.ch\/en\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/geneveinfos.ch\/wp-content\/uploads\/2025\/04\/geneve_infos_logo.png","@id":"https:\/\/geneveinfos.ch\/en\/#articleImage"},"datePublished":"2026-10-27T08:13:12+01:00","dateModified":"2026-10-31T11:53:03+01:00","inLanguage":"en-GB","mainEntityOfPage":{"@id":"https:\/\/geneveinfos.ch\/en\/2026\/10\/27\/resultats-trimestriels-un-echec-clinique-ampute-de-70-le-benefice-net-de-novartis\/#webpage"},"isPartOf":{"@id":"https:\/\/geneveinfos.ch\/en\/2026\/10\/27\/resultats-trimestriels-un-echec-clinique-ampute-de-70-le-benefice-net-de-novartis\/#webpage"},"articleSection":"Pharma &amp; biotech, Fiche bilingue"},{"@type":"BreadcrumbList","@id":"https:\/\/geneveinfos.ch\/en\/2026\/10\/27\/resultats-trimestriels-un-echec-clinique-ampute-de-70-le-benefice-net-de-novartis\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/geneveinfos.ch\/en\/#listItem","position":1,"name":"Home","item":"https:\/\/geneveinfos.ch\/en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/geneveinfos.ch\/en\/category\/pharma-biotech\/#listItem","name":"Pharma &amp; biotech"}},{"@type":"ListItem","@id":"https:\/\/geneveinfos.ch\/en\/category\/pharma-biotech\/#listItem","position":2,"name":"Pharma &amp; biotech","item":"https:\/\/geneveinfos.ch\/en\/category\/pharma-biotech\/","nextItem":{"@type":"ListItem","@id":"https:\/\/geneveinfos.ch\/en\/2026\/10\/27\/resultats-trimestriels-un-echec-clinique-ampute-de-70-le-benefice-net-de-novartis\/#listItem","name":"R\u00e9sultats trimestriels : un \u00e9chec clinique ampute de 70 % le b\u00e9n\u00e9fice net de Novartis"},"previousItem":{"@type":"ListItem","@id":"https:\/\/geneveinfos.ch\/en\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/geneveinfos.ch\/en\/2026\/10\/27\/resultats-trimestriels-un-echec-clinique-ampute-de-70-le-benefice-net-de-novartis\/#listItem","position":3,"name":"R\u00e9sultats trimestriels : un \u00e9chec clinique ampute de 70 % le b\u00e9n\u00e9fice net de Novartis","previousItem":{"@type":"ListItem","@id":"https:\/\/geneveinfos.ch\/en\/category\/pharma-biotech\/#listItem","name":"Pharma &amp; biotech"}}]},{"@type":"Organization","@id":"https:\/\/geneveinfos.ch\/en\/#organization","name":"Gen\u00e8ve Infos","description":"Revue de presse et analyses sur l'\u00e9conomie et l'urbanisme de Gen\u00e8ve.","url":"https:\/\/geneveinfos.ch\/en\/","logo":{"@type":"ImageObject","url":"https:\/\/geneveinfos.ch\/wp-content\/uploads\/2025\/04\/geneve_infos_logo.png","@id":"https:\/\/geneveinfos.ch\/en\/2026\/10\/27\/resultats-trimestriels-un-echec-clinique-ampute-de-70-le-benefice-net-de-novartis\/#organizationLogo"},"image":{"@id":"https:\/\/geneveinfos.ch\/en\/2026\/10\/27\/resultats-trimestriels-un-echec-clinique-ampute-de-70-le-benefice-net-de-novartis\/#organizationLogo"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61576016541234","https:\/\/www.instagram.com\/geneveinfos.ch?igsh=MXhkaTV2bXBkZm00NQ==","https:\/\/www.linkedin.com\/company\/geneveinfos-ch"]},{"@type":"Person","@id":"https:\/\/geneveinfos.ch\/en\/author\/wpra-source-author-site-1\/#author","url":"https:\/\/geneveinfos.ch\/en\/author\/wpra-source-author-site-1\/","name":"R\u00e9daction Gen\u00e8ve Infos","image":{"@type":"ImageObject","@id":"https:\/\/geneveinfos.ch\/en\/2026\/10\/27\/resultats-trimestriels-un-echec-clinique-ampute-de-70-le-benefice-net-de-novartis\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/4a611ac9406717aef02499144d0e12a8f5e1327b66a2e6023de2c094c4937e1d?s=96&d=mm&r=g","width":96,"height":96,"caption":"R\u00e9daction Gen\u00e8ve Infos"}},{"@type":"WebPage","@id":"https:\/\/geneveinfos.ch\/en\/2026\/10\/27\/resultats-trimestriels-un-echec-clinique-ampute-de-70-le-benefice-net-de-novartis\/#webpage","url":"https:\/\/geneveinfos.ch\/en\/2026\/10\/27\/resultats-trimestriels-un-echec-clinique-ampute-de-70-le-benefice-net-de-novartis\/","name":"R\u00e9sultats trimestriels : un \u00e9chec clinique ampute de 70 % le b\u00e9n\u00e9fice net de Novartis - Gen\u00e8ve Infos","description":"Novartis a pass\u00e9 une d\u00e9pr\u00e9ciation de pr\u00e8s de 2 milliards de dollars au troisi\u00e8me trimestre apr\u00e8s l\u2019\u00e9chec d\u2019une \u00e9tude clinique, ce qui fait chuter son b\u00e9n\u00e9fice net de 70 %.","inLanguage":"en-GB","isPartOf":{"@id":"https:\/\/geneveinfos.ch\/en\/#website"},"breadcrumb":{"@id":"https:\/\/geneveinfos.ch\/en\/2026\/10\/27\/resultats-trimestriels-un-echec-clinique-ampute-de-70-le-benefice-net-de-novartis\/#breadcrumblist"},"author":{"@id":"https:\/\/geneveinfos.ch\/en\/author\/wpra-source-author-site-1\/#author"},"creator":{"@id":"https:\/\/geneveinfos.ch\/en\/author\/wpra-source-author-site-1\/#author"},"datePublished":"2026-10-27T08:13:12+01:00","dateModified":"2026-10-31T11:53:03+01:00"},{"@type":"WebSite","@id":"https:\/\/geneveinfos.ch\/en\/#website","url":"https:\/\/geneveinfos.ch\/en\/","name":"Gen\u00e8ve Infos","description":"Le site d'informations de la r\u00e9gion genevoise","inLanguage":"en-GB","publisher":{"@id":"https:\/\/geneveinfos.ch\/en\/#organization"}}]},"og:locale":"en_GB","og:site_name":"Gen\u00e8ve Infos - Le site d'informations de la r\u00e9gion genevoise","og:type":"article","og:title":"R\u00e9sultats trimestriels : un \u00e9chec clinique ampute de 70 % le b\u00e9n\u00e9fice net de Novartis - Gen\u00e8ve Infos","og:description":"Novartis a pass\u00e9 une d\u00e9pr\u00e9ciation de pr\u00e8s de 2 milliards de dollars au troisi\u00e8me trimestre apr\u00e8s l\u2019\u00e9chec d\u2019une \u00e9tude clinique, ce qui fait chuter son b\u00e9n\u00e9fice net de 70 %.","og:url":"https:\/\/geneveinfos.ch\/en\/2026\/10\/27\/resultats-trimestriels-un-echec-clinique-ampute-de-70-le-benefice-net-de-novartis\/","og:image":"https:\/\/geneveinfos.ch\/wp-content\/uploads\/2026\/10\/geneveinfos-partage-1200x630-1.jpg","og:image:secure_url":"https:\/\/geneveinfos.ch\/wp-content\/uploads\/2026\/10\/geneveinfos-partage-1200x630-1.jpg","og:image:width":1200,"og:image:height":630,"article:published_time":"2026-10-27T07:13:12+00:00","article:modified_time":"2026-10-31T10:53:03+00:00","article:publisher":"https:\/\/www.facebook.com\/profile.php?id=61576016541234","twitter:card":"summary_large_image","twitter:title":"R\u00e9sultats trimestriels : un \u00e9chec clinique ampute de 70 % le b\u00e9n\u00e9fice net de Novartis - Gen\u00e8ve Infos","twitter:description":"Novartis a pass\u00e9 une d\u00e9pr\u00e9ciation de pr\u00e8s de 2 milliards de dollars au troisi\u00e8me trimestre apr\u00e8s l\u2019\u00e9chec d\u2019une \u00e9tude clinique, ce qui fait chuter son b\u00e9n\u00e9fice net de 70 %.","twitter:image":"https:\/\/geneveinfos.ch\/wp-content\/uploads\/2026\/10\/geneveinfos-partage-1200x630-1.jpg"},"aioseo_meta_data":{"post_id":"295834","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2026-10-27 07:47:32","updated":"2026-10-31 10:53:11","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/geneveinfos.ch\/en\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/geneveinfos.ch\/en\/category\/pharma-biotech\/\" title=\"Pharma &amp; biotech\">Pharma &amp; biotech<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tR\u00e9sultats trimestriels : un \u00e9chec clinique ampute de 70 % le b\u00e9n\u00e9fice net de Novartis\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/geneveinfos.ch\/en\/"},{"label":"Pharma &amp; biotech","link":"https:\/\/geneveinfos.ch\/en\/category\/pharma-biotech\/"},{"label":"R\u00e9sultats trimestriels : un \u00e9chec clinique ampute de 70 % le b\u00e9n\u00e9fice net de Novartis","link":"https:\/\/geneveinfos.ch\/en\/2026\/10\/27\/resultats-trimestriels-un-echec-clinique-ampute-de-70-le-benefice-net-de-novartis\/"}],"_links":{"self":[{"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/posts\/295834","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/comments?post=295834"}],"version-history":[{"count":2,"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/posts\/295834\/revisions"}],"predecessor-version":[{"id":305575,"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/posts\/295834\/revisions\/305575"}],"wp:attachment":[{"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/media?parent=295834"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/categories?post=295834"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/tags?post=295834"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}